# A Phase I Study of LY3471851 in Healthy Participants

> **NCT05565729** · PHASE1 · COMPLETED · sponsor: **Nektar Therapeutics** · enrollment: 41 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3471851
- **DRUG:** Placebo
- **DRUG:** Levocetirizine

## Key facts

- **NCT ID:** NCT05565729
- **Lead sponsor:** Nektar Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-05
- **Primary completion:** 2023-02-23
- **Final completion:** 2023-02-23
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2023-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05565729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05565729, "A Phase I Study of LY3471851 in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05565729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*